alendronic acid
Ligand Summary
A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
UNII: X1J18R4W8P
PubChem: 44400013
PubChem: 2088
PubChem: 16760285
Guide to Pharmacology: 3141
ChEMBL: CHEMBL870
ChEMBL: CHEMBL675
DrugCentral: 112
LyCHI: 941BJ1UYW842
Target Activities
12 Activities
Items per page:
1 – 10 of 12
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||